| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.004 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |